Westpac Banking Corp decreased its position in CME Group Inc. (NASDAQ:CME – Free Report) by 27.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 10,400 shares of the financial services provider’s stock after selling 3,930 shares during the period. Westpac Banking Corp’s holdings in CME Group were worth $2,725,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Brookmont Capital Management lifted its holdings in shares of CME Group by 0.6% in the 3rd quarter. Brookmont Capital Management now owns 5,661 shares of the financial services provider’s stock worth $1,483,000 after buying an additional 34 shares during the period. Harbour Wealth Management Group Inc. increased its stake in shares of CME Group by 1.6% during the third quarter. Harbour Wealth Management Group Inc. now owns 2,216 shares of the financial services provider’s stock valued at $581,000 after buying an additional 34 shares during the period. Manchester Capital Management LLC increased its stake in shares of CME Group by 2.9% during the third quarter. Manchester Capital Management LLC now owns 1,297 shares of the financial services provider’s stock valued at $340,000 after buying an additional 37 shares during the period. Grove Bank & Trust increased its stake in shares of CME Group by 0.8% during the third quarter. Grove Bank & Trust now owns 5,038 shares of the financial services provider’s stock valued at $1,320,000 after buying an additional 39 shares during the period. Finally, Intrua Financial LLC raised its holdings in shares of CME Group by 3.0% in the third quarter. Intrua Financial LLC now owns 1,334 shares of the financial services provider’s stock valued at $350,000 after acquiring an additional 39 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on CME. Bank of America increased their target price on shares of CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a report on Thursday, July 23rd. Piper Sandler restated an “overweight” rating and issued a $330.00 price target (up from $295.00) on shares of CME Group in a report on Thursday, October 22nd. CLSA set a $367.00 price target on shares of CME Group in a research report on Thursday, October 22nd. Deutsche Bank lowered shares of CME Group from a “buy” rating to a “hold” rating and cut their price objective for the company from $286.00 to $270.00 in a report on Wednesday, August 19th. Finally, Wells Fargo & Company lifted their price objective on shares of CME Group from $315.00 to $333.00 and gave the company an “overweight” rating in a report on Thursday, October 22nd. Ten research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, CME Group currently has an average rating of “Hold” and an average target price of $314.44.
Check Out Our Latest Report on CME Group
Insider Buying and Selling
In other news, Director Howard J. Siegel sold 2,000 shares of the stock in a transaction dated Monday, November 2nd. The stock was sold at an average price of $303.00, for a total value of $606,000.00. Following the transaction, the director directly owned 19,873 shares of the company’s stock, valued at approximately $6,021,519. This represents a 9.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Julie Winkler sold 10,079 shares of the firm’s stock in a transaction dated Monday, November 2nd. The stock was sold at an average price of $305.15, for a total value of $3,075,606.85. Following the completion of the transaction, the insider owned 21,482 shares of the company’s stock, valued at approximately $6,555,232.30. The trade was a 31.93% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 61,166 shares of company stock worth $18,276,512 over the last three months. Corporate insiders own 0.30% of the company’s stock.
Top CME Group Stories
Here are a few of the latest stories about CME:
- Neutral Sentiment: CEO Terrence Duffy discussed CME Group’s Tour Championship and prediction markets in a media interview, but the coverage provided no specific financial or business update. Article
- Neutral Sentiment: Several reports focus on CME Group’s LPGA Tour Championship sponsorship and tournament coverage. This may support brand visibility, but no direct near-term financial impact was reported. Article
- Negative Sentiment: Duffy sold 27,000 shares for about $8.36 million, reducing his direct stake by 43.24%. General Counsel John Clifford Marchese also sold 655 shares, an 18.20% reduction in his holdings. Insider sales can be made for personal reasons and do not necessarily signal a change in company outlook, but the CEO’s sale may weigh on sentiment. CEO filing General counsel filing
CME Group Price Performance
NASDAQ CME opened at $306.31 on Friday. The firm’s fifty day simple moving average is $288.79 and its two-hundred day simple moving average is $282.00. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16. The firm has a market capitalization of $109.64 billion, a P/E ratio of 25.13, a P/E/G ratio of 3.79 and a beta of 0.15. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.
CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, topping the consensus estimate of $2.99 by $0.03. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.71 billion. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The company’s quarterly revenue was up 10.6% on a year-over-year basis. During the same quarter last year, the company earned $2.68 earnings per share. Analysts forecast that CME Group Inc. will post 12.35 EPS for the current fiscal year.
CME Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 30th. Investors of record on Friday, December 11th will be given a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Friday, December 11th. CME Group’s dividend payout ratio is presently 42.66%.
About CME Group
CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.
See Also
- Five stocks we like better than CME Group
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
